Abstract Details
|
Elizabeth T. Troy, MD
(University of Colorado)
PRESENTER |
The institution of Dr. Troy has received research support from ABPN. The institution of Dr. Troy has received research support from American Academy of Neurology. Dr. Troy has received publishing royalties from a publication relating to health care. Dr. Troy has received publishing royalties from a publication relating to health care. |
| Timothy Bernard, MD (U of Colorado Denver and Children's Hospital) | The institution of Dr. Bernard has received research support from NIH. |
| John Binder, MD (U of CO) | Dr. Binder has nothing to disclose. |
| Aaron M. Carlson, MD (University of Colorado, School of Medicine, Department of Neurology) | Dr. Carlson has received research support from Horizon Therapeutics (Amgen). |
| Hannah Gilbert, MD | Dr. Gilbert has nothing to disclose. |
| Jan A. Martin, MD (University of Washington/Seattle Children's Hospital) | Dr. Martin has nothing to disclose. |
| Jeremy Moeller, MD, FAAN (Yale University) | Dr. Moeller has received publishing royalties from a publication relating to health care. |
| Scott Rosenthal, MD (University of Colorado) | Dr. Rosenthal has a non-compensated relationship as a Sub-Investigator with Biohaven and Teva that is relevant to AAN interests or activities. |
| Michelle Tutmaher, DO (Children's Hospital Colorado) | Dr. Tutmaher has nothing to disclose. |
| TAI M. LOCKSPEISER, MD | Dr. LOCKSPEISER has nothing to disclose. |